✦ LIBER ✦

Combination of lymphokine-activated killer cells and interleukin-2 in treating metastatic renal cell carcinoma

✍ Scribed by T. FUJIOKA; K. NOMURA; M. HASEGAWA; K. ISHIKURA; T. KUBO

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival characteristics of metastatic r

✍ Deric D. Schoof; Yasunori Terashima; Steven Batter; Linda Douville; Jerome P. Ri 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 720 KB

Immunotherapy with interleukin-2 (IL2) a

✍ Escudier, B; Farace, F; Angevin, E; Charpentier, F; Nitenberg, G; Triebel, F; He 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Treatment of hepatocellular carcinoma ut

✍ Takafumi Ichida; Kiyohiro Higuchi; Kenji Arakawa; Hironobu Ohta; Kazuko Sugiyama 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 784 KB

Combination of interleukin-2 and gamma i

✍ Escudier, B.; Antoun, S.; Leclercq, B.; Nitenberg, G.; Farace, F.; Angevin, E.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 470 KB

Severe intrahepatic cholestasis in patie

✍ Mitchel Hoffman; Abraham Mittelman; Brad Dworkin; William Rosenthal; Deborah Ben 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 1014 KB

Different susceptibilities of lymphokine

✍ T. Hattori; M. Satoh; T. Nishimura; N. Kawamura; M. Akimoto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB